Cancer BiologybioRxivPreprint
53BP1 mediates sensitivity to chemotherapy and is associated with poor clinical outcomes in high-grade serous ovarian cancer
Michael Skulimowski, Jessica Bourbonnais, Nicolas Malaquin…·Françis Rodier
This study shows that high 53BP1 levels in ovarian cancer are linked to poor survival and chemotherapy resistance, suggesting it could be a therapeutic target.
DOI 10.1101/2023.09.30.560286